First Time Loading...

Theralase Technologies Inc
XTSX:TLT

Watchlist Manager
Theralase Technologies Inc Logo
Theralase Technologies Inc
XTSX:TLT
Watchlist
Price: 0.16 CAD Market Closed
Updated: May 6, 2024

Theralase Technologies Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theralase Technologies Inc
Revenue Peer Comparison

Comparables:
NVCN
PRN
OPS
NSCI
MIR

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Theralase Technologies Inc
XTSX:TLT
Revenue
CA$1.1m
CAGR 3-Years
5%
CAGR 5-Years
-9%
CAGR 10-Years
-1%
Neovasc Inc
TSX:NVCN
Revenue
$3.8m
CAGR 3-Years
22%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Profound Medical Corp
TSX:PRN
Revenue
$7.2m
CAGR 3-Years
0%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Opsens Inc
TSX:OPS
Revenue
CA$48.4m
CAGR 3-Years
18%
CAGR 5-Years
15%
CAGR 10-Years
20%
Nanalysis Scientific Corp
XTSX:NSCI
Revenue
CA$24.8m
CAGR 3-Years
44%
CAGR 5-Years
26%
CAGR 10-Years
N/A
MedMira Inc
XTSX:MIR
Revenue
CA$407.8k
CAGR 3-Years
-47%
CAGR 5-Years
-6%
CAGR 10-Years
-14%

See Also

What is Theralase Technologies Inc's Revenue?
Revenue
1.1m CAD

Based on the financial report for Dec 31, 2023, Theralase Technologies Inc's Revenue amounts to 1.1m CAD.

What is Theralase Technologies Inc's Revenue growth rate?
Revenue CAGR 10Y
-1%

Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for Theralase Technologies Inc have been 5% over the past three years , -9% over the past five years , and -1% over the past ten years .